Trial intelligence / Profile preview

Clomiphene Citrate +/- Sildenafil Citrate for Ovulation Induction in PCOS

NCT07769476Phase 4Completed

Sponsor
Nishtar Medical University
Start
Jul 2025
Primary completion
Dec 2025
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ASP-001 in polycystic ovary syndrome (PCOS) and subfertility (2 arms), sponsored by Nishtar Medical University. Primary endpoint: Pregnancy Rate at 12 weeks. Started Jul 2025; status: completed.

02

Drugs

ASP-001
03

Conditions

polycystic ovary syndrome (PCOS)subfertility

Beyond the preview

Go deeper on NCT07769476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07769476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call